James Hamilton

James Hamilton is a dynamic and self-motivated pharmacology research scientist with nearly a decade of experience in neuroscience, neurodegeneration, and mitochondrial biology. They earned a PhD in Pharmacology from Indiana University School of Medicine, where their dissertation focused on mitochondrial dysfunction in Huntington’s disease. Currently, James works as the Manager of Global Scientific Communications at Eli Lilly and Company, after serving as a postdoctoral research scientist specializing in neurodegeneration. They have published 12 papers in peer-reviewed journals and delivered over 25 presentations, demonstrating strong communication skills and expertise in various laboratory techniques.